KEYNOTE-564: A phase 3, randomized, double blind, trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma

Autor:	Howard Gurney, Andrey Semenov, Wayne Yen-Hwa Chang, Francis Parnis, Jae-Lyun Lee, Shuyan M. Wan, Tian Zhang, Se Hoon Park, Gurjyot K. Doshi, Christian Heinrich Poehlein, Toni K. Choueiri, David I. Quinn, Thomas Powles, Patrick Wayne Cobb
Rok vydání:	2018
Předmět:	Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment 030232 urology & nephrology Urology food and beverages Pembrolizumab urologic and male genital diseases medicine.disease Nephrectomy Double blind 03 medical and health sciences 0302 clinical medicine Oncology Renal cell carcinoma 030220 oncology & carcinogenesis Advanced disease Medicine business Adjuvant
Zdroj:	Journal of Clinical Oncology. 36:TPS4599-TPS4599
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.tps4599
Popis:	TPS4599Background: The typical management for renal cell carcinoma (RCC) is nephrectomy. Despite this, patients with intermediate- to high-risk advanced disease can experience relapse with metastat...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8877ce7ea81a028c6f00f9aaa936bcd6 https://doi.org/10.1200/jco.2018.36.15_suppl.tps4599 Zobrazit plný text záznamu